{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:44:46Z","timestamp":1785282286220,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Military Infectious Disease Research Program Office of USAMRMC"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.vaccine.2011.07.124","type":"journal-article","created":{"date-parts":[[2011,8,8]],"date-time":"2011-08-08T14:05:45Z","timestamp":1312812345000},"page":"7752-7758","source":"Crossref","is-referenced-by-count":23,"title":["An experimental outer membrane vesicle vaccine from N. meningitidis serogroup B strains that induces serum bactericidal activity to multiple serogroups"],"prefix":"10.1016","volume":"29","author":[{"given":"Valerian B.","family":"Pinto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth E.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Fridman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendell D.","family":"Zollinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig T.","family":"Przysiecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Burden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2011.07.124_bib0005","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1084\/jem.129.6.1349","article-title":"Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides","volume":"129","author":"Gotschlich","year":"1969","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.vaccine.2011.07.124_bib0010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0092-1157(82)80010-3","article-title":"Tetravalent meningococcal polysaccharide vaccine groups A, C, Y, W 135: clinical and serological evaluation","volume":"10","author":"Armand","year":"1982","journal-title":"J Biol Stand"},{"issue":"12","key":"10.1016\/j.vaccine.2011.07.124_bib0015","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1128\/CVI.00207-09","article-title":"Quadrivalent meningococcal vaccination of adults: phase III comparison of an investigational conjugate vaccine, MenACWY-CRM, with the licensed vaccine, Menactra","volume":"16","author":"Reisinger","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"41","key":"10.1016\/j.vaccine.2011.07.124_bib0020","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1016\/j.vaccine.2009.07.036","article-title":"Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages","volume":"27","author":"Br\u00f6ker","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2011.07.124_bib0025","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"13","author":"Finne","year":"1983","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2011.07.124_bib0030","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann"},{"issue":"8827","key":"10.1016\/j.vaccine.2011.07.124_bib0035","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0140-6736(92)93086-3","article-title":"Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil","volume":"340","author":"de Moraes","year":"1992","journal-title":"Lancet"},{"issue":"8775","key":"10.1016\/j.vaccine.2011.07.124_bib0040","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against serogroup B meningococcal disease in Norway","volume":"338","author":"Bjune","year":"1991","journal-title":"Lancet"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2011.07.124_bib0045","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.vaccine.2005.01.063","article-title":"MeNZB\u2122: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain","volume":"23","author":"Oster","year":"2005","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2011.07.124_bib0050","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0264-410X(94)00037-N","article-title":"and the Chilean national Committee for Meningococcal Disease. Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile","volume":"13","author":"Boslego","year":"1995","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2011.07.124_bib0055","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines. A randomized controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0060","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1086\/597806","article-title":"Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa","volume":"199","author":"Beernink","year":"2009","journal-title":"JID"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2011.07.124_bib0065","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1086\/648966","article-title":"Review of meningococcal group B vaccines","volume":"50","author":"Granoff","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0070","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0075","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","article-title":"Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease","volume":"28","author":"Jiang","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0080","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1016\/j.vaccine.2010.05.006","article-title":"Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine","volume":"28","author":"Zollinger","year":"2010","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2011.07.124_bib0085","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00255-09","article-title":"Characterization of an antibody assay for analysis of bactericidal antibody specificity","volume":"16","author":"Zollinger","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2011.07.124_bib0090","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1128\/IAI.62.12.5290-5295.1994","article-title":"Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity","volume":"62","author":"Moran","year":"1994","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2011.07.124_bib0095","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.vaccine.2010.11.072","article-title":"Distribution of factor H binding protein beyond serogroup B: variation among five serogroups of invasive Neisseria meningitidis in South Africa","volume":"29","author":"Mothibeli","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2011.07.124_bib0100","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1128\/CVI.00252-07","article-title":"Specificity of the sub-capsular antibody responses following serogroup A meningococcal disease in Ethiopian patients","volume":"15","author":"Norheim","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0105","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.1016\/j.vaccine.2010.09.031","article-title":"GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis","volume":"28","author":"Lu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2217\/17460913.3.1.23","article-title":"Serotype-specific problems associated with pneumococcal conjugate vaccination","volume":"3","author":"Hanage","year":"2008","journal-title":"Future Microbiol"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0115","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.297.16.1784","article-title":"Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage","volume":"297","author":"Singleton","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0120","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa0800836","article-title":"Effect of pneumococcal conjugate vaccine on pneumococcal meningitis","volume":"360","author":"Hsu","year":"2009","journal-title":"NEJM"},{"issue":"10","key":"10.1016\/j.vaccine.2011.07.124_bib0125","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0264-410X(96)00020-5","article-title":"Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine","volume":"14","author":"Claassen","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0130","series-title":"Abstracts of the 14th international pathogenic Neisseria conference","first-page":"153","article-title":"From HexaMen to NonaMen: expanding a multivalent PorA-based meningococcal outer membrane vesicle vaccine","author":"Van Den Dobbelsteen","year":"2004"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0135","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1128\/IAI.01108-08","article-title":"Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response","volume":"77","author":"Weynants","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0882-4010(92)90022-G","article-title":"The lipooligosaccharide immunotype as a virulence determinant in Neisseria meningitidis","volume":"13","author":"Jones","year":"1992","journal-title":"Microb Pathog"},{"issue":"9","key":"10.1016\/j.vaccine.2011.07.124_bib0145","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1128\/CVI.00129-10","article-title":"Three doses of an experimental detoxified L3-derived lipooligosaccharide meningococcal vaccine offer good safety but low immunogenicity in healthy young adults","volume":"17","author":"Bonhevi","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0150","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.vaccine.2010.12.039","article-title":"A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression","volume":"29","author":"Keiser","year":"2011","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.vaccine.2011.07.124_bib0155","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2011.07.124_bib0160","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.vaccine.2005.01.056","article-title":"Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B","volume":"23","author":"Pillai","year":"2005","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2011.07.124_bib0165","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/656741","article-title":"Multicenter, open-label, randomized Phase II controlled trial of an investigational recombinant meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy","volume":"51","author":"Findlow","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2011.07.124_bib0170","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani","year":"2003","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.vaccine.2011.07.124_bib0175","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1128\/CVI.00542-10","article-title":"A critical threshold of meningococcal factor H binding protein expression is required for increased breadth of protective antibodies elicited by mative outer membrane vesicles vaccines","volume":"18","author":"Koeberling","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0180","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/j.vaccine.2003.11.005","article-title":"Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model","volume":"22","author":"David","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0185","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.vaccine.2004.07.007","article-title":"Risk factors for acellular and whole-cell pertussis vaccine failure in Senegalese children","volume":"23","author":"Lacombe","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0190","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0264-410X(00)00253-X","article-title":"Investigation of cellular and humoral immune responses to whole cell and acellular pertussis vaccines","volume":"19","author":"Canthaboo","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0195","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1128\/JB.180.20.5478-5483.1998","article-title":"Gram-negative bacteria produce membrane vesicles which are capable of killing other bacteria","volume":"180","author":"Li","year":"1998","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0200","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1128\/JB.133.3.1419-1426.1978","article-title":"Physiological characterization of an Escherichia coli mutant altered in the structure of murein lipoprotein","volume":"133","author":"Yem","year":"1978","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0205","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/JB.136.1.280-285.1978","article-title":"Cell envelope and shape of Escherichia coli: multiple mutants missing the outer membrane Lipoprotein and other major outer membrane proteins","volume":"136","author":"Sonntag","year":"1978","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0210","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.resmic.2004.04.007","article-title":"Improved methods for producing outer membrane vesicles in Gram-negative bacteria","volume":"155","author":"Henry","year":"2004","journal-title":"Res Microbiol"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0215","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1128\/IAI.00532-08","article-title":"Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice","volume":"76","author":"Schild","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0220","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0928-8244(03)00091-9","article-title":"Differences in immunogenicity and protection in mice and guinea pigs following intranasal immunization with Helicobacter pylori outer membrane antigens","volume":"36","author":"Keenan","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0225","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.4049\/jimmunol.179.11.7692","article-title":"Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo","volume":"179","author":"Alaniz","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0230","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1128\/IAI.70.9.5096-5106.2002","article-title":"Attenuated Salmonella enteric serovar Typhi expressing urease effectively immunizes mice against helicobacter pylori challenge as part of a heterologous mucosal priming parenteral boosting vaccination regimen","volume":"70","author":"Londo\u00f1o-Arcila","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0235","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.vaccine.2010.12.068","article-title":"Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate","volume":"29","author":"Asencio","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0240","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0264-410X(02)00774-0","article-title":"Comparison of functional immune responses in humans after intranasal and intramuscular immunizations with outer membrane vesicle vaccines against group B meningococcal disease","volume":"21","author":"Aase","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0245","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1128\/IAI.69.8.5010-5015.2001","article-title":"Meningococcal outer membrane vesicle vaccine given intranasally cen induce immunological memory and booster responses without evidence of tolerance","volume":"69","author":"Bakke","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.07.124_bib0250","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0264-410X(02)00591-1","article-title":"Serum bactericidal activity correlates with vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease","volume":"21","author":"Holst","year":"2003","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11011741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11011741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T04:07:24Z","timestamp":1592798844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11011741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":50,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0264410X11011741"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.07.124","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}